Contrarily, the loss of significance in the inverse risk association between adiponectin and endometrial cancer when considering only type 2 endometrial cancers could be attributed to the general perception that type 2 endometrial cancer is obesity independent. The gene discussed is ADIPOQ; the disease is obesity disorder.